Hackett Patrick T. - 07 Mar 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Mar 2025, 16:19:22 UTC
Prior SEC filing
29 May 2024
Next SEC filing
04 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: John L Brottem For: Patrick T Hackett

Key filing fact

Hackett Patrick T. filed Form 4 for Outset Medical, Inc. (OM) on 11 Mar 2025.

Key facts

  • This page summarizes Hackett Patrick T.'s Form 4 filing for Outset Medical, Inc. (OM).
  • 9 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 11 Mar 2025, 16:19.

Change

  • Previous filing in this sequence was filed on 29 May 2024.
  • Current net transaction value: +$2,500,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,250,000
Change %
+2917%
Price
Shares after
1,292,849
Date
10 Mar 2025
Ownership
Direct
Footnotes
F1
OM transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,250,000
Change %
Price
Shares after
1,250,000
Date
10 Mar 2025
Ownership
GST Trust
Footnotes
F1
OM transaction

Common Stock

Options Exercise

Transaction value
Shares
+625,000
Change %
Price
Shares after
625,000
Date
10 Mar 2025
Ownership
Hackett Family Fund
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OM transaction Derivative

Series A Non-Voting Convertible Preferred

Award

Transaction value
$1,000,000
Shares
+5,000
Change %
Price
$200.00
Shares after
5,000
Date
07 Mar 2025
Ownership
Direct
Underlying class
Preferred Stock
Underlying amount
5,000
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Options Exercise

Transaction value
$0
Shares
-5,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
10 Mar 2025
Ownership
Direct
Underlying class
Preferred Stock
Underlying amount
5,000
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Award

Transaction value
$1,000,000
Shares
+5,000
Change %
Price
$200.00
Shares after
5,000
Date
07 Mar 2025
Ownership
GST Trust
Underlying class
Preferred Stock
Underlying amount
5,000
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Options Exercise

Transaction value
Shares
-5,000
Change %
-100%
Price
Shares after
0
Date
10 Mar 2025
Ownership
GST Trust
Underlying class
Preferred Stock
Underlying amount
5,000
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Award

Transaction value
$500,000
Shares
+2,500
Change %
Price
$200.00
Shares after
2,500
Date
07 Mar 2025
Ownership
Hackett Family Fund
Underlying class
Preferred Stock
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F2
OM transaction Derivative

Series A Non-Voting Convertible Preferred

Options Exercise

Transaction value
$0
Shares
-2,500
Change %
-100%
Price
$0.000000
Shares after
0
Date
10 Mar 2025
Ownership
Hackett Family Fund
Underlying class
Preferred Stock
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

Footnote F2

These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .